Media
Latest News
The Childhood Cancer Caucus applauds Dr. Harold Varmus, the Director of the National Cancer Institute (NCI), for announcing the appointment of Dr. Greg Aune, a pediatric hematologist-oncologist from The University of Texas Health Science Center at San Antonio, to NCI's Council of Research Advocates.
On September 30th, the U.S. Food and Drug Administration announced it has awarded 15 grants totaling more than $19 million to boost the development of medical device, drug, and biological products for patients with rare diseases, with at least a quarter of the funding going to studies focused solely on pediatrics. $1.6 million will go toward a Phase 2 Study of Poly-ICLC for the Treatment of Pediatric Low Grade Gliomas, the most common type of brain tumor in children.
On September 19, Dr. Francis Collins, the Director of the National Institutes of Health (NIH), announced a new pediatric trial for children with cancer. Sponsored by the National Cancer Institute (NCI), the Molecular Analysis for Therapy Choice Program (MATCH) trial will enroll children with advanced cancers that have progressed on standard therapy.
On Friday, September 19, the Childhood Cancer Caucus will host its 5th Annual Childhood Cancer Summit: "Pediatric Cancer: Major Advances, Major Challenges".
Advocates for those with childhood cancers will tell lawmakers Tuesday that more funding is badly needed to help research and treat the diseases.
Members of the Alliance for Childhood Cancer are calling on congressional leaders to pass the Caroline Pryce Walker Conquer Childhood Cancer Reauthorization Act and increase funding to the National Cancer Institute (NCI).
Issues:
Caucus Asks Questions about the Ongoing Shortage of Daunorubicin
Representatives McCaul and Van Hollen send letters to the FDA and Teva Pharmacueticals to seek more information about the ongoing shortage of daunorubicin, an essential therapy in the treatment of leukemia in children.
Pediatricians and child health advocates joined members of Congress Thursday for the Fourth Annual Congressional Childhood Cancer Caucus.
Doctors say they're making progress in treating pediatric diseases and developing new drugs.
The research has been made possible under the Creating Hope Act, co-sponsored by Austin Area Representative Michael McCaul.
Budget battles in Washington have made some
Progress into research and development of the first new pediatric cancer drugs in nearly 30 years was announced at the 4th Annual Congressional Childhood Cancer Summit on Capitol Hill on September 19, 2013.
Issues:
Creating Hope Act of 2011
Usually, when Brianna Commerford misses school, her mom has to write a note to her principal that says ‘doctor’s appointment’ or ‘sick.’ This one said ‘speaking on Capitol Hill.’
“When I was nine years old, I was diagnosed with stage four Hodgkins’ Lymphoma,” the 14-year-old told the third annual Childhood Cancer Summit Thursday.
When Commerford was diagnosed in 2007, she was taken out of school